Cargando…
Serum levels of S100A6 are unaltered in patients with resectable cholangiocarcinoma
BACKGROUND: Elevated expression levels of S100A6, a calcium-binding low-molecular-weight protein, were demonstrated in various malignancies. Moreover, increased serum levels of S100A6 were suggested as a novel biomarker for various inflammatory and malignant diseases including lung and gastric cance...
Autores principales: | Loosen, Sven H., Benz, Fabian, Niedeggen, Jennifer, Schmeding, Maximilian, Schüller, Florian, Koch, Alexander, Vucur, Mihael, Tacke, Frank, Trautwein, Christian, Roderburg, Christoph, Neumann, Ulf P., Luedde, Tom |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5052241/ https://www.ncbi.nlm.nih.gov/pubmed/27709523 http://dx.doi.org/10.1186/s40169-016-0120-7 |
Ejemplares similares
-
Levels of Circulating PD-L1 Are Decreased in Patients with Resectable Cholangiocarcinoma
por: Roderburg, Christoph, et al.
Publicado: (2021) -
A Combined Score of Circulating miRNAs Allows Outcome Prediction in Critically Ill Patients
por: Roderburg, Christoph, et al.
Publicado: (2019) -
Elevated Omentin Serum Levels Predict Long-Term Survival in Critically Ill Patients
por: Luedde, Mark, et al.
Publicado: (2016) -
CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma
por: Loosen, Sven H., et al.
Publicado: (2017) -
Serum Levels of miR-143 Predict Survival in Critically Ill Patients
por: Roderburg, Christoph, et al.
Publicado: (2019)